Tobias Gedde-Dahl
Position:
Phone:
Email:
 

Author network for Tobias Gedde-Dahl by COREMINE medical


Publications 2017

Canaani J, Beohou E, Labopin M, Socié G, Huynh A, Volin L, Cornelissen J, Milpied N, Gedde-Dahl T, Deconinck E, Fegueux N, Blaise D, Mohty M, Nagler A (2017)
Impact of FAB classification on predicting outcome in acute myeloid leukemia, not otherwise specified, patients undergoing allogeneic stem cell transplantation in CR1: An analysis of 1690 patients from the acute leukemia working party of EBMT
Am J Hematol, 92 (4), 344-350
PubMed 28052366

Canaani J, Labopin M, Socié G, Nihtinen A, Huynh A, Cornelissen J, Deconinck E, Gedde-Dahl T, Forcade E, Chevallier P, Bourhis JH, Blaise D, Mohty M, Nagler A (2017)
Long term impact of hyperleukocytosis in newly diagnosed acute myeloid leukemia patients undergoing allogeneic stem cell transplantation: An analysis from the acute leukemia working party of the EBMT
Am J Hematol, 92 (7), 653-659
PubMed 28370339

Gullaksen SE, Skavland J, Gavasso S, Tosevski V, Warzocha K, Dumrese C, Ferrant A, Gedde-Dahl T, Hellmann A, Janssen J, Labar B, Lang A, Majeed W, Mihaylov G, Stentoft J, Stenke L, Thaler J, Thielen N, Verhoef G, Voglova J, Ossenkoppele G, Hochhaus A, Hjorth-Hansen H, Mustjoki S, Sopper S et al. (2017)
Single cell immune profiling by mass cytometry of newly diagnosed chronic phase chronic myeloid leukaemia treated with nilotinib
Haematologica (in press)
PubMed 28522574

Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2017)
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
Bone Marrow Transplant, 52 (7), 1081
PubMed 28677682

Publications 2016

Fløisand Y, Lundin KE, Lazarevic V, Kristiansen JD, Osnes LT, Tjønnfjord GE, Reims HM, Gedde-Dahl T (2016)
Targeting Integrin α4β7 in Steroid-Refractory Intestinal Graft-versus-Host Disease
Biol Blood Marrow Transplant, 23 (1), 172-175
PubMed 27777142

Hjorth-Hansen H, Stentoft J, Richter J, Koskenvesa P, Höglund M, Dreimane A, Porkka K, Gedde-Dahl T, Gjertsen BT, Gruber FX, Stenke L, Eriksson KM, Markevärn B, Lübking A, Vestergaard H, Udby L, Bjerrum OW, Persson I, Mustjoki S, Olsson-Strömberg U (2016)
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients
Leukemia, 30 (9), 1853-60
PubMed 27133821

Ilander M, Olsson-Strömberg U, Schlums H, Guilhot J, Brück O, Lähteenmäki H, Kasanen T, Koskenvesa P, Söderlund S, Höglund M, Markevärn B, Själander A, Lotfi K, Dreimane A, Lübking A, Holm E, Björeman M, Lehmann S, Stenke L, Ohm L, Gedde-Dahl T, Majeed W, Ehrencrona H, Koskela S, Saussele S et al. (2016)
Increased proportion of mature NK cells is associated with successful imatinib discontinuation in chronic myeloid leukemia
Leukemia, 31 (5), 1108-1116
PubMed 27890936

Koenecke C, Heim D, van Biezen A, Heuser M, Aljurf M, Kyrcz-Krzemien S, Volin L, de Souza CA, Gedde-Dahl T, Sengeloev H, Schanz U, Komarnicki M, Arroyo CH, Tholouli E, Gluckman E, Esquirol A, Yakoub-Agha I, Gürman G, Olavarria E, Kröger N (2016)
Outcome of patients with chronic myeloid leukemia and a low-risk score: allogeneic hematopoietic stem cell transplantation in the era of targeted therapy. A report from the EBMT Chronic Malignancies Working Party
Bone Marrow Transplant, 51 (9), 1259-61
PubMed 27111041

Robin M, Porcher R, Zinke-Cerwenka W, van Biezen A, Volin L, Mufti G, Craddock C, Finke J, Richard C, Passweg J, Peniket A, Maertens J, Sucak G, Gedde-Dahl T, Vitek A, Nagler A, Blaise D, Beelen D, Maillard N, Schwerdtfeger R, de Witte T, Kroger N (2016)
Allogeneic haematopoietic stem cell transplant in patients with lower risk myelodysplastic syndrome: a retrospective analysis on behalf of the Chronic Malignancy Working Party of the EBMT
Bone Marrow Transplant, 52 (2), 209-215
PubMed 27819688

Samarakoon P, Gambin T, Chinn IK, Akdemir ZHC, Erichsen HC, Forbes LR, Gu S, Yuan B, Jhangiani SN, Muzny DM, Rødningen OK, Sheng Y, Nicholas SK, Noroski LM, Seeborg FO, Davis C, Canter D, Mace EM, Vece T, Allen CE, Abhyankar HA, Boone P, Beck CR, Wiszniewski WK, Fevang B et al. (2016)
Primary immunodeficiency diseases: Genomic approaches delineate heterogeneous Mendelian disorders
J Allergy Clin Immunol, 139 (1), 232-245
PubMed 27577878

Tvedt TH, Lie SA, Reikvam H, Rye KP, Lindås R, Gedde-Dahl T, Ahmed AB, Bruserud Ø (2016)
Pretransplant Levels of CRP and Interleukin-6 Family Cytokines; Effects on Outcome after Allogeneic Stem Cell Transplantation
Int J Mol Sci, 17 (11)
PubMed 27809289

Publications 2015

Bazarbachi A, Labopin M, Kharfan-Dabaja MA, Schwerdtfeger R, Volin L, Bourhis JH, Socié G, Daguindau E, Gedde-Dahl T, Rambaldi A, Karas M, Schlimok G, Blaise D, Chevallier P, Malard F, Schmid C, Esteve J, Nagler A, Mohty M (2015)
Allogeneic hematopoietic cell transplantation in acute myeloid leukemia with normal karyotype and isolated Nucleophosmin-1 (NPM1) mutation: outcome strongly correlates with disease status
Haematologica, 101 (1), e34-7
PubMed 26405153

Bremer S, Fløisand Y, Brinch L, Gedde-Dahl T, Bergan S (2015)
Glutathione Transferase Gene Variants Influence Busulfan Pharmacokinetics and Outcome After Myeloablative Conditioning
Ther Drug Monit, 37 (4), 493-500
PubMed 25565670

Publications 2014

Bruserud Ø, Tvedt TH, Paulsen PQ, Ahmed AB, Gedde-Dahl T, Tjønnfjord GE, Slåstad H, Heldal D, Reikvam H (2014)
Extracorporeal photopheresis (photochemotherapy) in the treatment of acute and chronic graft versus host disease: immunological mechanisms and the results from clinical studies
Cancer Immunol Immunother, 63 (8), 757-77
PubMed 24997173

Hallstensen RF, Bergseth G, Foss S, Jæger S, Gedde-Dahl T, Holt J, Christiansen D, Lau C, Brekke OL, Armstrong E, Stefanovic V, Andersen JT, Sandlie I, Mollnes TE (2014)
Eculizumab treatment during pregnancy does not affect the complement system activity of the newborn
Immunobiology, 220 (4), 452-9
PubMed 25468724

Hjorth-Hansen H, Stenke L, Söderlund S, Dreimane A, Ehrencrona H, Gedde-Dahl T, Gjertsen BT, Höglund M, Koskenvesa P, Lotfi K, Majeed W, Markevärn B, Ohm L, Olsson-Strömberg U, Remes K, Suominen M, Simonsson B, Porkka K, Mustjoki S, Richter J, Nordic CML Study Group (2014)
Dasatinib induces fast and deep responses in newly diagnosed chronic myeloid leukaemia patients in chronic phase: clinical results from a randomised phase-2 study (NordCML006)
Eur J Haematol, 94 (3), 243-50
PubMed 25082346

Husøy MA, Brinch L, Tjønnfjord GE, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I, Kolstad A, Akkök ÇA, Rollag H, Gaustad P, Bergan S, Egeland T, Josefsen D, Kvalheim G, Fløisand Y (2014)
[Allogeneic stem-cell transplantation in adults 1985-2012: results and development]
Tidsskr Nor Laegeforen, 134 (16), 1569-75
PubMed 25178233

Publications 2013

Mellqvist UH, Gimsing P, Hjertner O, Lenhoff S, Laane E, Remes K, Steingrimsdottir H, Abildgaard N, Ahlberg L, Blimark C, Dahl IM, Forsberg K, Gedde-Dahl T, Gregersen H, Gruber A, Guldbrandsen N, Haukås E, Carlson K, Kvam AK, Nahi H, Lindås R, Andersen NF, Turesson I, Waage A, Westin J et al. (2013)
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial
Blood, 121 (23), 4647-54
PubMed 23616624

Mustjoki S, Richter J, Barbany G, Ehrencrona H, Fioretos T, Gedde-Dahl T, Gjertsen BT, Hovland R, Hernesniemi S, Josefsen D, Koskenvesa P, Dybedal I, Markevärn B, Olofsson T, Olsson-Strömberg U, Rapakko K, Thunberg S, Stenke L, Simonsson B, Porkka K, Hjorth-Hansen H, Nordic CML Study Group (NCMLSG) (2013)
Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients
Leukemia, 27 (7), 1520-6
PubMed 23328954

Publications 2012

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE, Dybedal I, Holte H, Heldal D, Torfoss D, Aurlien E, Lauritzsen GF, Fosså A, Lehne G, Baggerød E, Kvalheim G, Egeland T, Bishop MR, Fowler DH, Kolstad A (2012)
Ultra-short course sirolimus contributes to effective GVHD prophylaxis after reduced-intensity allogeneic hematopoietic cell transplantation
Bone Marrow Transplant, 47 (12), 1552-7
PubMed 22522568

Publications 2011

Frøyland M, Ruffini PA, Thompson KM, Gedde-Dahl T, Fredriksen AB, Bogen B (2011)
Targeted idiotype-fusion DNA vaccines for human multiple myeloma: preclinical testing
Eur J Haematol, 86 (5), 385-95
PubMed 21332794

Gruber FX, Lundán T, Goll R, Silye A, Mikkola I, Rekvig OP, Knuutila S, Remes K, Gedde-Dahl T, Porkka K, Hjorth-Hansen H (2011)
BCR-ABL isoforms associated with intrinsic or acquired resistance to imatinib: more heterogeneous than just ABL kinase domain point mutations?
Med Oncol, 29 (1), 219-26
PubMed 21221851

Simonsson B, Gedde-Dahl T, Markevärn B, Remes K, Stentoft J, Almqvist A, Björeman M, Flogegård M, Koskenvesa P, Lindblom A, Malm C, Mustjoki S, Myhr-Eriksson K, Ohm L, Räsänen A, Sinisalo M, Själander A, Strömberg U, Bjerrum OW, Ehrencrona H, Gruber F, Kairisto V, Olsson K, Sandin F, Nagler A et al. (2011)
Combination of pegylated IFN-α2b with imatinib increases molecular response rates in patients with low- or intermediate-risk chronic myeloid leukemia
Blood, 118 (12), 3228-35
PubMed 21685374

Publications 2010

Johnsen HE, Klausen TW, Boegsted M, Lenhoff S, Gimsing P, Christiansen I, Gedde-Dahl T, Lindås R, Mellqvist UH, Nordic Myeloma Study Group (2010)
Improved survival for multiple myeloma in denmark based on autologous stem cell transplantation and novel drug therapy in collaborative trials: analysis of accrual, prognostic variables, selection bias, and clinical behavior on survival in more than 1200 patients in trials of the nordic myeloma study group
Clin Lymphoma Myeloma Leuk, 10 (4), 290-6
PubMed 20709667

Publications 2009

Andresen PA, Heimdal K, Aaberg K, Eklo K, Ariansen S, Silye A, Fausa O, Aabakken L, Aretz S, Eide TJ, Gedde-Dahl T (2009)
APC mutation spectrum of Norwegian familial adenomatous polyposis families: high ratio of novel mutations
J Cancer Res Clin Oncol, 135 (10), 1463-70
PubMed 19444466

Vefring HK, Gruber FX, Wee L, Hovland R, Hjorth-Hansen H, Gedde Dahl T, Meyer P (2009)
Chronic myelogenous leukemia with the e6a2 BCR-ABL and lacking imatinib response: presentation of two cases
Acta Haematol, 122 (1), 11-6
PubMed 19641300

Publications 2008

Brinch L, Tjønnfjord G, Gedde-Dahl T, Heldal D, Holme PA, Dybedal I (2008)
[Allogeneic stem cell transplantation in acute myelogenous leukemia]
Tidsskr Nor Laegeforen, 128 (15), 1681-2; author reply 1682
PubMed 18704137

Fløisand Y, Brinch L, Dybedal I, Gedde-Dahl T, Heldal D, Holme PA, Egeland T, Tjønnfjord GE (2008)
[Allogeneic stem cell transplantation in adults with acute lymphoblastic leukaemia]
Tidsskr Nor Laegeforen, 128 (22), 2563-6
PubMed 19023351

Larson RA, Druker BJ, Guilhot F, O'Brien SG, Riviere GJ, Krahnke T, Gathmann I, Wang Y, IRIS (International Randomized Interferon vs STI571) Study Group (2008)
Imatinib pharmacokinetics and its correlation with response and safety in chronic-phase chronic myeloid leukemia: a subanalysis of the IRIS study
Blood, 111 (8), 4022-8
PubMed 18256322

Publications 2007

Andresen PA, Johansen T, Eide TJ, Gedde-Dahl T (2007)
Gene symbol: APC
Hum Genet, 121 (2), 288
PubMed 17598199

Dahlqvist J, Klar J, Hausser I, Anton-Lamprecht I, Pigg MH, Gedde-Dahl T, Gånemo A, Vahlquist A, Dahl N (2007)
Congenital ichthyosis: mutations in ichthyin are associated with specific structural abnormalities in the granular layer of epidermis
J Med Genet, 44 (10), 615-20
PubMed 17557927

Frøyland M, Thompson KM, Thorpe SJ, Sahota SS, Gedde-Dahl T, Bogen B (2007)
A VH4-34+ myeloma protein with weak autoreactivity
Haematologica, 92 (5), 690-3
PubMed 17488696

Tjønnfjord GE, Gedde-Dahl T, Heldal D, Brinch L (2007)
Treatment outcome in adults with acute lymphoblastic leukemia: 50% long-term disease-free survival
Leukemia, 21 (10), 2203-4
PubMed 17525727

Publications 2006

Frangu M, Gedde-Dahl T, Verder H (2006)
[Epidermolysis bullosa simplex Dowling-Meara]
Ugeskr Laeger, 168 (48), 4222-4
PubMed 17147951

Publications 2005

Gruber FX, Lamark T, Anonli A, Sovershaev MA, Olsen M, Gedde-Dahl T, Hjort-Hansen H, Skogen B (2005)
Selecting and deselecting imatinib-resistant clones: observations made by longitudinal, quantitative monitoring of mutated BCR-ABL
Leukemia, 19 (12), 2159-65
PubMed 16224487

Mathisen B, Loennechen T, Gedde-Dahl T, Winberg JO (2005)
Fibroblast heterogeneity in collagenolytic response to colchicine
Biochem Pharmacol, 71 (5), 574-83
PubMed 16378602

Publications 2004

Corthay A, Lundin KU, Munthe LA, Frøyland M, Gedde-Dahl T, Dembic Z, Bogen B (2004)
Immunotherapy in multiple myeloma: Id-specific strategies suggested by studies in animal models
Cancer Immunol Immunother, 53 (9), 759-69
PubMed 15088126

Fløisand Y, Brinch L, Gedde-Dahl T, Tjønnfjord GE (2004)
[Treatment of T-cell prolymphocytic leukemia with monoclonal anti- CD52 antibody (alemtuzumab]
Tidsskr Nor Laegeforen, 124 (6), 768-70
PubMed 15039804

Klar J, Gedde-Dahl T, Larsson M, Pigg M, Carlsson B, Tentler D, Vahlquist A, Dahl N (2004)
Assignment of the locus for ichthyosis prematurity syndrome to chromosome 9q33.3-34.13
J Med Genet, 41 (3), 208-12
PubMed 14985385

Koss-Harnes D, Høyheim B, Jonkman MF, de Groot WP, de Weerdt CJ, Nikolic B, Wiche G, Gedde-Dahl T (2004)
Life-long course and molecular characterization of the original Dutch family with epidermolysis bullosa simplex with muscular dystrophy due to a homozygous novel plectin point mutation
Acta Derm Venereol, 84 (2), 124-31
PubMed 15206692

Tjønnfjord GE, Brinch L, Gedde-Dahl T, Brosstad FR (2004)
Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX
Haemophilia, 10 (2), 174-8
PubMed 14962207

Publications 2003

Virtanen M, Smith SK, Gedde-Dahl T, Vahlquist A, Bowden PE (2003)
Splice site and deletion mutations in keratin (KRT1 and KRT10) genes: unusual phenotypic alterations in Scandinavian patients with epidermolytic hyperkeratosis
J Invest Dermatol, 121 (5), 1013-20
PubMed 14708600

Publications 2002

Koss-Harnes D, Høyheim B, Anton-Lamprecht I, Gjesti A, Jørgensen RS, Jahnsen FL, Olaisen B, Wiche G, Gedde-Dahl T (2002)
A site-specific plectin mutation causes dominant epidermolysis bullosa simplex Ogna: two identical de novo mutations
J Invest Dermatol, 118 (1), 87-93
PubMed 11851880

Lind B, Gedde-Dahl T, Tjønnfjord G, Villoutreix BO, Brosstad F (2002)
Protein C deficiency caused by homozygosity for a novel PROC D180G mutation--in vitro expression and structural analysis of the mutation
Thromb Haemost, 88 (4), 632-8
PubMed 12362235

Van Maldergem L, Magré J, Khallouf TE, Gedde-Dahl T, Delépine M, Trygstad O, Seemanova E, Stephenson T, Albott CS, Bonnici F, Panz VR, Medina JL, Bogalho P, Huet F, Savasta S, Verloes A, Robert JJ, Loret H, De Kerdanet M, Tubiana-Rufi N, Mégarbané A, Maassen J, Polak M, Lacombe D, Kahn CR et al. (2002)
Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy
J Med Genet, 39 (10), 722-33
PubMed 12362029

Publications 2001

Andresen PA, Gedde-Dahl T, Fausa O, Eide TJ, Heiberg A (2001)
[Genetic analysis in familial adenomatous polyposis]
Tidsskr Nor Laegeforen, 121 (1), 64-8
PubMed 12013617

Magré J, Delépine M, Khallouf E, Gedde-Dahl T, Van Maldergem L, Sobel E, Papp J, Meier M, Mégarbané A, Bachy A, Verloes A, d'Abronzo FH, Seemanova E, Assan R, Baudic N, Bourut C, Czernichow P, Huet F, Grigorescu F, de Kerdanet M, Lacombe D, Labrune P, Lanza M, Loret H, Matsuda F et al. (2001)
Identification of the gene altered in Berardinelli-Seip congenital lipodystrophy on chromosome 11q13
Nat Genet, 28 (4), 365-70
PubMed 11479539

Nordal EJ, Mecklenbeck S, Hausser I, Skranes J, Bruckner-Tuderman L, Gedde-Dahl T (2001)
Generalized dystrophic epidermolysis bullosa: identification of a novel, homozygous glycine substitution, G2031S, in exon 73 of COL7A1 in monozygous triplets
Br J Dermatol, 144 (1), 151-7
PubMed 11167698

Skotheim RI, Kraggerud SM, Fosså SD, Stenwig AE, Gedde-Dahl T, Danielsen HE, Jakobsen KS, Lothe RA (2001)
Familial/bilateral and sporadic testicular germ cell tumors show frequent genetic changes at loci with suggestive linkage evidence
Neoplasia, 3 (3), 196-203
PubMed 11494113

van Leusden MR, Pas HH, Gedde-Dahl T, Sonnenberg A, Jonkman MF (2001)
Truncated typeXVII collagen expression in a patient with non-herlitz junctional epidermolysis bullosa caused by a homozygous splice-site mutation
Lab Invest, 81 (6), 887-94
PubMed 11406649

Virtanen M, Gedde-Dahl T, Mörk NJ, Leigh I, Bowden PE, Vahlquist A (2001)
Phenotypic/genotypic correlations in patients with epidermolytic hyperkeratosis and the effects of retinoid therapy on keratin expression
Acta Derm Venereol, 81 (3), 163-70
PubMed 11558869

Publications 2000

Dupuy BM, Gedde-Dahl T, Olaisen B (2000)
DXYS267: DYS393 and its X chromosome counterpart
Forensic Sci Int, 112 (2-3), 111-21
PubMed 10940596

Pigg M, Gedde-Dahl T, Cox DW, Haugen G, Dahl N (2000)
Haplotype association and mutation analysis of the transglutaminase 1 gene for prenatal exclusion of lamellar ichthyosis
Prenat Diagn, 20 (2), 132-7
PubMed 10694685

Publications 1999

Apelland T, Gedde-Dahl T, Dietrichson T (1999)
[Serotonin syndrome with fatal outcome caused by selective serotonin reuptake inhibitors]
Tidsskr Nor Laegeforen, 119 (5), 647-50
PubMed 10095385

Publications 1998

Dupuy BM, Gedde-Dahl T, Olaisen B (1998)
Comparisons of allele frequencies in three hyperpolymorphic STRs between Norwegian Saamis and the main population
INT CONGR SER, 1167, 395-397

Pigg M, Gedde-Dahl T, Cox D, Hausser I, Anton-Lamprecht I, Dahl N (1998)
Strong founder effect for a transglutaminase 1 gene mutation in lamellar ichthyosis and congenital ichthyosiform erythroderma from Norway
Eur J Hum Genet, 6 (6), 589-96
PubMed 9887377

Publications 1997

Koss-Harnes D, Jahnsen FL, Wiche G, Søyland E, Brandtzaeg P, Gedde-Dahl T (1997)
Plectin abnormality in epidermolysis bullosa simplex Ogna: non-responsiveness of basal keratinocytes to some anti-rat plectin antibodies
Exp Dermatol, 6 (1), 41-8
PubMed 9067706

Scheffer H, Stulp RP, Verlind E, van der Meulen M, Bruckner-Tuderman L, Gedde-Dahl T, te Meerman GJ, Sonnenberg A, Buys CH, Jonkman MF (1997)
Implications of intragenic marker homozygosity and haplotype sharing in a rare autosomal recessive disorder: the example of the collagen type XVII (COL17A1) locus in generalised atrophic benign epidermolysis bullosa
Hum Genet, 100 (2), 230-5
PubMed 9254855

Winberg JO, Hammami-Hauasli N, Nilssen O, Anton-Lamprecht I, Naylor SL, Kerbacher K, Zimmermann M, Krajci P, Gedde-Dahl T, Bruckner-Tuderman L (1997)
Modulation of disease severity of dystrophic epidermolysis bullosa by a splice site mutation in combination with a missense mutation in the COL7A1 gene
Hum Mol Genet, 6 (7), 1125-35
PubMed 9215684

Publications 1996

Chan YM, Cheng J, Gedde-Dahl T, Niemi KM, Fuchs E (1996)
Genetic analysis of a severe case of Dowling-Meara epidermolysis bullosa simplex
J Invest Dermatol, 106 (2), 327-34
PubMed 8601736

Gedde-Dahl T, Trygstad O, Van Maldergem L, Magré J, van der Hagen CB, Olaisen B, Stenersen M, Mevåg B (1996)
Genetics of the Berardinelli-Seip syndrome (congenital generalized lipodystrophy) in Norway: epidemiology and gene mapping. Berardinelli-Seip Study Group
Acta Paediatr Suppl, 413, 52-8
PubMed 8783773

Gjertsen MK, Bakka A, Breivik J, Saeterdal I, Gedde-Dahl T, Stokke KT, Sølheim BG, Egge TS, Søreide O, Thorsby E, Gaudernack G (1996)
Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study
Int J Cancer, 65 (4), 450-3
PubMed 8621226

Jonkman MF, de Jong MC, Heeres K, Steijlen PM, Owaribe K, Küster W, Meurer M, Gedde-Dahl T, Sonnenberg A, Bruckner-Tuderman L (1996)
Generalized atrophic benign epidermolysis bullosa. Either 180-kd bullous pemphigoid antigen or laminin-5 deficiency
Arch Dermatol, 132 (2), 145-50
PubMed 8629821

Lyngstadaas SP, Nordbo H, Gedde-Dahl T, Thrane PS (1996)
On the genetics of hypodontia and microdontia: synergism or allelism of major genes in a family with six affected members
J Med Genet, 33 (2), 137-42
PubMed 8929951

Uttam J, Hutton E, Coulombe PA, Anton-Lamprecht I, Yu QC, Gedde-Dahl T, Fine JD, Fuchs E (1996)
The genetic basis of epidermolysis bullosa simplex with mottled pigmentation
Proc Natl Acad Sci U S A, 93 (17), 9079-84
PubMed 8799157

Publications 1995

Bruckner-Tuderman L, Nilssen O, Zimmermann DR, Dours-Zimmermann MT, Kalinke DU, Gedde-Dahl T, Winberg JO (1995)
Immunohistochemical and mutation analyses demonstrate that procollagen VII is processed to collagen VII through removal of the NC-2 domain
J Cell Biol, 131 (2), 551-9
PubMed 7593178

Cox DW, Gedde-Dahl T, Menon AG, Nygaard TG, Tomlinson IM, Peters J, St George-Hyslop PH, Walter MA, Edwards JH (1995)
Report of the second international workshop on human chromosome 14 mapping 1994
Cytogenet Cell Genet, 69 (3-4), 159-74
PubMed 7698004

Sajantila A, Lahermo P, Anttinen T, Lukka M, Sistonen P, Savontaus ML, Aula P, Beckman L, Tranebjaerg L, Gedde-Dahl T, Issel-Tarver L, DiRienzo A, Pääbo S (1995)
Genes and languages in Europe: an analysis of mitochondrial lineages
Genome Res, 5 (1), 42-52
PubMed 8717054

Publications 1994

Fossum B, Breivik J, Meling GI, Gedde-Dahl T, Hansen T, Knutsen I, Rognum TO, Thorsby E, Gaudernack G (1994)
A K-ras 13Gly-->Asp mutation is recognized by HLA-DQ7 restricted T cells in a patient with colorectal cancer. Modifying effect of DQ7 on established cancers harbouring this mutation?
Int J Cancer, 58 (4), 506-11
PubMed 7914513

Fossum B, Gedde-Dahl T, Breivik J, Eriksen JA, Spurkland A, Thorsby E, Gaudernack G (1994)
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly-->Asp)
Int J Cancer, 56 (1), 40-5
PubMed 7903287

Gedde-Dahl T, Dupuy BM, Jonassen R, Winberg JO, Anton-Lamprecht I, Olaisen B (1994)
Junctional epidermolysis bullosa inversa (locus EBR2A) assigned to 1q31 by linkage and association to LAMC1
Hum Mol Genet, 3 (8), 1387-91
PubMed 7987320

Gedde-Dahl T, Nilsen E, Thorsby E, Gaudernack G (1994)
Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras
Cancer Immunol Immunother, 38 (2), 127-34
PubMed 8306368

Gedde-Dahl T, Spurkland A, Fossum B, Wittinghofer A, Thorsby E, Gaudernack G (1994)
T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA
Eur J Immunol, 24 (2), 410-4
PubMed 7507844

Gedde-Dahl T, Winberg JO (1994)
Neonatal retention of type VII collagen, transient bullous dermolysis of the newborn and recessive epidermolysis bullosa dystrophica inversa
Br J Dermatol, 130 (5), 685-6
PubMed 8204486

Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
Binding of ras oncogene peptides to purified HLA-DQ (alpha 1*0102, beta 1*0602) and -DR (alpha, beta 1*0101) molecules
Scand J Immunol, 40 (4), 468
PubMed 7939420

Johansen BH, Gedde-Dahl T, Sollid LM, Vartdal F, Thorsby E, Gaudernack G (1994)
Binding of ras oncogene peptides to purified HLA-DQ(alpha 1*0102,beta 1*0602) and -DR(alpha,beta 1*0101) molecules
Scand J Immunol, 39 (6), 607-12
PubMed 8009176

König A, Winberg JO, Gedde-Dahl T, Bruckner-Tuderman L (1994)
Heterogeneity of severe dystrophic epidermolysis bullosa: overexpression of collagen VII by cutaneous cells from a patient with mutilating disease
J Invest Dermatol, 102 (2), 155-9
PubMed 8106746

Spurkland A, Gedde-Dahl T, Hansen T, Vartdal F, Gaudernack G, Thorsby E (1994)
Heterogeneity of T cells specific for a particular peptide/HLA-DQ complex
Hum Immunol, 39 (1), 61-8
PubMed 8181964

Verrando P, Lissitzky JC, Sarret Y, Winberg JO, Gedde-Dahl T, Schmitt D, Bruckner-Tuderman L (1994)
Keratinocytes from junctional epidermolysis bullosa do adhere and migrate on the basement membrane protein nicein through alpha 3 beta 1 integrin
Lab Invest, 71 (4), 567-74
PubMed 7967512

Publications 1993

Fossum B, Gedde-Dahl T, Hansen T, Eriksen JA, Thorsby E, Gaudernack G (1993)
Overlapping epitopes encompassing a point mutation (12 Gly-->Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells
Eur J Immunol, 23 (10), 2687-91
PubMed 7691613

Gedde-Dahl T, Fossum B, Eriksen JA, Thorsby E, Gaudernack G (1993)
T cell clones specific for p21 ras-derived peptides: characterization of their fine specificity and HLA restriction
Eur J Immunol, 23 (3), 754-60
PubMed 8449222

Gedde-Dahl T, Olsen BH, Thorsby E, Gaudernack G (1993)
Oncogene-derived peptides: a new class of tumor rejection antigens?
Transplant Proc, 25 (1 Pt 2), 1385-6
PubMed 8442151

Hansen T, Spurkland A, Lundin KE, Gjertsen H, Gedde-Dahl T, Qvigstad E, Markussen G, Thorsby E (1993)
Studies of the T-cell receptors of T cells recognizing the same HLA molecule
Transplant Proc, 25 (1 Pt 1), 72
PubMed 8438455

Publications 1992

Bruckner-Tuderman L, Winberg JO, Anton-Lamprecht I, Schnyder UW, Gedde-Dahl T (1992)
Anchoring fibrils, collagen VII, and neutral metalloproteases in recessive dystrophic epidermolysis bullosa inversa
J Invest Dermatol, 99 (5), 550-8
PubMed 1431215

Gedde-Dahl T (1992)
Symposium on epidermolysis bullosa
J Med Genet, 29 (5), 354-5
PubMed 1349925

Gedde-Dahl T, Eriksen JA, Thorsby E, Gaudernack G (1992)
T-cell responses against products of oncogenes: generation and characterization of human T-cell clones specific for p21 ras-derived synthetic peptides
Hum Immunol, 33 (4), 266-74
PubMed 1639630

Gedde-Dahl T, Spurkland A, Eriksen JA, Thorsby E, Gaudernack G (1992)
Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln-->Leu61)
Int Immunol, 4 (11), 1331-7
PubMed 1282032

Krajci P, Gedde-Dahl T, Høyheim B, Rogde S, Olaisen B, Brandtzaeg P (1992)
The gene encoding human transmembrane secretory component (locus PIGR) is linked to D1S58 on chromosome 1
Hum Genet, 90 (3), 215-9
PubMed 1487233

Rogde S, Gedde-Dahl T, Teisberg P, Jonassen R, Høyheim B, Olaisen B (1992)
Linkage and association studies with C8A and C8B RFLPs on chromosome 1
Ann Hum Genet, 56 (Pt 3), 233-42
PubMed 1360193

Winberg JO, Gedde-Dahl T (1992)
Epidermolysis bullosa simplex: expression of gelatinase activity in cultured human skin fibroblasts
Biochem Genet, 30 (7-8), 401-20
PubMed 1445183

Publications 1991

Rogne S, Myklebost O, Olving JH, Kyrkjebø HT, Jonassen R, Olaisen B, Gedde-Dahl T (1991)
The human genes for complement components 6 (C6) and 9 (C9) are closely linked on chromosome 5
J Med Genet, 28 (9), 587-90
PubMed 1683409

Publications 1990

Cox DW, Nakamura Y, Gedde-Dahl T (1990)
Report of the committee on the genetic constitution of chromosome 14
Cytogenet Cell Genet, 55 (1-4), 183-8
PubMed 2073832

Lothe RA, Brøgger A, Gedde-Dahl T (1990)
High-resolution karyotypes of eighteen Norwegian polyposis patients
Cancer Genet Cytogenet, 47 (1), 69-72
PubMed 2162732

Rogne S, Mevåg B, Gedde-Dahl T, Myklebost O (1990)
Multiple RFLPs of human complement component nine (C9) detected by TaqI
Nucleic Acids Res, 18 (10), 3112
PubMed 1971940

Publications 1989

Andresen PA, Gedde-Dahl T, Bergan A, Berstad T, Sellgren AC (1989)
[A Norwegian polyposis family. From catastrophe to prevention]
Tidsskr Nor Laegeforen, 109 (7-8), 832-5
PubMed 2539657

Gedde-Dahl T, Heim S, Lothe R, Bye R, Geitvik GA, Kyrkjebø HT, Hognestad J, Nygaard K, Bergan A, Olaisen B (1989)
[The polyposis project]
Nord Med, 104 (1), 12-5
PubMed 2536147

Rogne S, Myklebost O, Høyheim B, Olaisen B, Gedde-Dahl T (1989)
The genes for apolipoprotein all (APOA2) and the Duffy blood group (FY) are linked on chromosome 1 in man
Genomics, 4 (2), 169-73
PubMed 2500391

Winberg JO, Gedde-Dahl T, Bauer EA (1989)
Collagenase expression in skin fibroblasts from families with recessive dystrophic epidermolysis bullosa
J Invest Dermatol, 92 (1), 82-5
PubMed 2535863

Publications 1988

Beighton P, de Paepe A, Danks D, Finidori G, Gedde-Dahl T, Goodman R, Hall JG, Hollister DW, Horton W, McKusick VA (1988)
International Nosology of Heritable Disorders of Connective Tissue, Berlin, 1986
Am J Med Genet, 29 (3), 581-94
PubMed 3287925

Cox DW, Gedde-Dahl T (1988)
Report of the committee on the genetic constitution of chromosomes 14 and 15
Cytogenet Cell Genet, 49 (1-3), 90-3
PubMed 3203557

Garber JE, Li FP, Kingston JE, Krush AJ, Strong LC, Finegold MJ, Bertario L, Bülow S, Filippone A, Gedde-Dahl T (1988)
Hepatoblastoma and familial adenomatous polyposis
J Natl Cancer Inst, 80 (20), 1626-8
PubMed 2848134

Gedde-Dahl T, Heim S, Lothe R, Bye R, Brevik K, Geitvik GA, Kyrkjebø HT, Hognestad J, Nygaard K, Bergan A (1988)
[The polyposis project]
Tidsskr Nor Laegeforen, 108 (29), 2465-8
PubMed 2905084

Lothe RA, Nakamura Y, Woodward S, Gedde-Dahl T, White R (1988)
VNTR (variable number of tandem repeats) markers show loss of chromosome 17p sequences in human colorectal carcinomas
Cytogenet Cell Genet, 48 (3), 167-9
PubMed 2906851

Teisberg P, Jonassen R, Mevåg B, Gedde-Dahl T, Olaisen B (1988)
Restriction fragment length polymorphisms of the complement component C4 loci on chromosome 6: studies with emphasis on the determination of gene number
Ann Hum Genet, 52 (Pt 2), 77-84
PubMed 2907852

Publications 1987

Gedde-Dahl T (1987)
The human gene map and genes expressed in the skin
Curr Probl Dermatol, 16, 45-64
PubMed 3556034

Gedde-Dahl T (1987)
Epidermolysis bullosa syndromes
Curr Probl Dermatol, 16, 129-45
PubMed 3581883

Geitvik GA, Høyheim B, Gedde-Dahl T, Grzeschik KH, Lothe R, Tomter H, Olaisen B (1987)
The Kidd (JK) blood group locus assigned to chromosome 18 by close linkage to a DNA-RFLP
Hum Genet, 77 (3), 205-9
PubMed 2890568

Hovig E, Winberg JO, Fodstad O, Brøgger A, Gedde-Dahl T (1987)
Chromosome 13 instability and esterase D expression in an osteosarcoma cell line
Cancer Genet Cytogenet, 24 (2), 327-34
PubMed 2878716

Lothe RA, Gedde-Dahl T, Lier ME, Aamdahl S, Bergan A, Stenwig AE, Broegger A (1987)
Loss of one chromosome #13 during development of a polyposis tumor
Cancer Genet Cytogenet, 28 (2), 335-42
PubMed 2887278

Ropers HH, Gedde-Dahl T, Cox DW (1987)
Report of the committee on the genetic constitution of chromosomes 13, 14, 15 amd 16
Cytogenet Cell Genet, 46 (1-4), 213-41
PubMed 3507275

Publications 1986

Gedde-Dahl T (1986)
Clinical heterogeneity in epidermolysis bullosa: speculations on causation and consequence for research
J Invest Dermatol, 86 (2), 91-3
PubMed 3745948

Lothe RA, Gedde-Dahl T, Olaisen B, Bakker E, Pearson P (1986)
Very close linkage between D2S1 and ACP1 on chromosome 2p
Ann Hum Genet, 50 (Pt 4), 361-7
PubMed 3481680

Rogde S, Olaisen B, Gedde-Dahl T, Teisberg P (1986)
The C8A and C8B loci are closely linked on chromosome 1
Ann Hum Genet, 50 (Pt 2), 139-44
PubMed 3435043

Rogne S, Myklebost O, Olaisen B, Gedde-Dahl T, Prydz H (1986)
Confirmation of the close linkage between the loci for human apolipoproteins AI and AIV by the use of a cloned cDNA probe and two restriction site polymorphisms
Hum Genet, 72 (1), 68-71
PubMed 3002953

Winberg JO, Gedde-Dahl T (1986)
Gelatinase expression in generalized epidermolysis bullosa simplex fibroblasts
J Invest Dermatol, 87 (3), 326-9
PubMed 3016106

Publications 1985

Cox DR, Gedde-Dahl T (1985)
Report of the Committee on the Genetic Constitution of Chromosomes 13, 14, 15 and 16
Cytogenet Cell Genet, 40 (1-4), 206-41
PubMed 3864595

Eriksson AW, Foltmann B, Frants RR, Gedde-Dahl T, Samloff IM, Taggart RT (1985)
Nomenclature Committee report: pepsinogens. Nomenclature Committee of Human Gene Mapping Conference
Prog Clin Biol Res, 173, 41-2
PubMed 3983197

Gedde-Dahl T (1985)
On chromosome mapping of human pepsinogen gene loci
Prog Clin Biol Res, 173, 101-6
PubMed 3983190

Gedde-Dahl T, Hannisdal E, Klepp OH, Grøttum KA, Waksvik H, Fosså SD, Stenwig AE, Brøogger A (1985)
Testicular neoplasms occurring in four brothers. A search for a genetic predisposition
Cancer, 55 (9), 2005-9
PubMed 2983872

Hansen MF, Koufos A, Gallie BL, Phillips RA, Fodstad O, Brøgger A, Gedde-Dahl T, Cavenee WK (1985)
Osteosarcoma and retinoblastoma: a shared chromosomal mechanism revealing recessive predisposition
Proc Natl Acad Sci U S A, 82 (18), 6216-20
PubMed 2994066

Olaisen B, Gedde-Dahl T, Teisberg P, Thorsby E, Siverts A, Jonassen R, Wilhelmy MC (1985)
A structural locus for coagulation factor XIIIA (F13A) is located distal to the HLA region on chromosome 6p in man
Am J Hum Genet, 37 (1), 215-20
PubMed 2858156

Rogde S, Mevåg B, Teisberg P, Gedde-Dahl T, Tedesco F, Olaisen B (1985)
Genetic polymorphism of complement component C8
Hum Genet, 70 (3), 211-6
PubMed 3879968

Publications 1984

Gedde-Dahl T, Olaisen B, Teisberg P, Wilhelmy MC, Mevåg B, Helland R (1984)
The locus for apolipoprotein E (apoE) is close to the Lutheran (Lu) blood group locus on chromosome 19
Hum Genet, 67 (2), 178-82
PubMed 6745937

Myklebost O, Rogne S, Olaisen B, Gedde-Dahl T, Prydz H (1984)
The locus for apolipoprotein CII is closely linked to the apolipoprotein E locus on chromosome 19 in man
Hum Genet, 67 (3), 309-12
PubMed 6088388

Schamaun O, Olaisen B, Mevåg B, Gedde-Dahl T, Ehnholm C, Teisberg P (1984)
The two apolipoprotein loci apo A-I and apo A-IV are closely linked in man
Hum Genet, 68 (2), 181-4
PubMed 6500569

Publications 1983

Olaisen B, Teisberg P, Jonassen R, Thorsby E, Gedde-Dahl T (1983)
Gene order and gene distances in the HLA region studied by the haplotype method
Ann Hum Genet, 47 (Pt 4), 285-92
PubMed 6418058

Schamaun O, Olaisen B, Gedde-Dahl T, Teisberg P (1983)
Genetic studies of an apoA-I lipoprotein variant
Hum Genet, 64 (4), 380-3
PubMed 6413385

Publications 1982

Gedde-Dahl T (1982)
Final eradication of tuberculosis in Norway?
J Oslo City Hosp, 32 (9), 107-9
PubMed 7143132

Olaisen B, Teisberg P, Gedde-Dahl T (1982)
The locus for apolipoprotein E (apoE) is linked to the complement component C3 (C3) locus on chromosome 19 in man
Hum Genet, 62 (3), 233-6
PubMed 7169215

Olaisen B, Teisberg P, Gedde-Dahl T (1982)
Fibrinogen gamma chain locus is on chromosome 4 in man
Hum Genet, 61 (1), 24-6
PubMed 6957371

Weitkamp LR, Berg K, Gedde-Dahl T, Hulten MA, McAlpine PJ, Sandberg K, Spence MA (1982)
Workshop on mapping by classical methods
Prog Clin Biol Res, 103 Pt A, 141-4
PubMed 7163191

Publications 1981

Gedde-Dahl T (1981)
Sixteen types of epidermolysis bullosa. On the clinical discrimination, therapy and prenatal diagnosis
Acta Derm Venereol Suppl (Stockh), 95, 74-87
PubMed 6953718

Gedde-Dahl T, Frants RR, Olaisen B, Eriksson AW, van Loghem E, Lamm L (1981)
The Gm--Pi linkage heterogeneity in view of Pi M subtypes
Ann Hum Genet, 45 (Pt 2), 143-53
PubMed 6797346

Nordhagen R, Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1981)
C4 haplotype products and partial inhibition of anti-Rodgers sera
J Immunogenet, 8 (6), 485-91
PubMed 7334218

Olaisen B, Siverts A, Jonassen R, Mevåg B, Gedde-Dahl T (1981)
The ESD polymorphism: further studies of the ESD2 and ESD5 allele products
Hum Genet, 57 (4), 351-3
PubMed 7286974

Olaisen B, Teisberg P, Jonassen R, Gedde-Dahl T, Moen T, Thorsby E (1981)
Complement loci of the HLA complex. Studies on families with intra-HLA crossovers and haplotype associations
Hum Immunol, 2 (3), 247-54
PubMed 6455398

Publications 1980

Korsnes L, Gedde-Dahl T (1980)
Genetics of pepsinogen I
Ann Hum Genet, 43 (3), 199-212
PubMed 6767433

Korsnes L, Gedde-Dahl T, Olaisen B, Thorsby E, Olving J, Siverts A, Bratlie A (1980)
Genetic linkage relation to the pepsinogen Pg5 locus
Ann Hum Genet, 44 (Pt 2), 185-94
PubMed 7316469

Nordhagen R, Olaisen B, Teisberg P, Gedde-Dahl T (1980)
Association between the electrophoretically-determined C4M haplotype product and partial inhibition of anti-Cha
J Immunogenet, 7 (4), 301-6
PubMed 6161195

Teisberg P, Olaisen B, Gedde-Dahl T, Thorsby E, Nordhagen R (1980)
Further investigations on the genetics of the C+ protein polymorphism
Immunobiology, 158 (1-2), 45-9
PubMed 7203519

Publications 1979

Fischer T, Gedde-Dahl T (1979)
Epidermolysis bullosa simplex and mottled pigmentation: a new dominant syndrome. I. Clinical and histological features
Clin Genet, 15 (3), 228-38
PubMed 421361

Olaisen B, Teisberg P, Jonassen R, Gedde-Dahl T (1979)
The C4 system: formal and population genetics
Hum Genet, 50 (2), 187-92
PubMed 511133

Olaisen B, Teisberg P, Nordhagen R, Michaelsen T, Gedde-Dahl T (1979)
Human complement C4 locus is duplicated on some chromosomes
Nature, 279 (5715), 736-7
PubMed 450123

Olving JH, Olaisen B, Gedde-Dahl T, Teisberg P (1979)
Genetic linkage relations of the sixth component of complement (C6)
Hum Genet, 46 (2), 181-92
PubMed 422202

Publications 1978

Bennick A, Gedde-Dahl T, brøgger A (1978)
Mapping with B-cell hybrids
Cytogenet Cell Genet, 22 (1-6), 661-5
PubMed 313313

Gedde-Dahl T, Hansteen IL, Fagerhol MK, Olaisen B (1978)
Regional chromosome 12 mapping: information from a family with a (12;21) reciprocal translocation
Cytogenet Cell Genet, 22 (1-6), 478-81
PubMed 752526

Gedde-Dahl T, Korsnes L, Thorsby E, Olaisen B, Bratlie A, Siverts A (1978)
Pepsinogens: new variant and linkage relationships to chromosome 6 markers
Cytogenet Cell Genet, 22 (1-6), 301-3
PubMed 752491

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1978)
Genetic polymorphism of the second component of human complement (C2): presentation of a modified typing technique and data on C2 phenotype distribution, linkage genetics, and haplotype associations a Norwegian family material
Hum Genet, 42 (3), 301-5
PubMed 669711

Olaisen B, Teisberg P, Jonassen R, Gedde-Dahl T, Olving JH, Siverts A, Bratlie A, Thorsby E (1978)
Structural complement factor loci and the HLA region
Cytogenet Cell Genet, 22 (1-6), 421-7
PubMed 752517

Publications 1977

Bauer EA, Gedde-Dahl T, Eisen AZ (1977)
The role of human skin collagenase in epidermolysis bullosa
J Invest Dermatol, 68 (3), 119-24
PubMed 190326

Gedde-Dahl T, Thorsby E (1977)
HLA and epidermolysis bullosa
Arch Dermatol, 113 (12), 1722-3
PubMed 596909

Olving JH, Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1977)
Nonlinkage between C6 and chromosome 6 markers
Hum Genet, 37 (2), 125-9
PubMed 885533

Teisberg P, Olaisen B, Jonassen R, Gedde-Dahl T, Thorsby E (1977)
The genetic polymorphism of the fourth component of human complement: methodological aspects and a presentation of linkage and association data relevant to its localization in the HLA region
J Exp Med, 146 (5), 1380-9
PubMed 925607

Publications 1976

Brogger A, Gedde-Dahl T, Olaisen B (1976)
Linkage data on 3q11 and 15ps fluorescence markers
Cytogenet Cell Genet, 16 (1-5), 275-6
PubMed 975889

Elston RC, Namboodiri KK, Lange K, Gedde-Dahl T (1976)
Effect of age on the Gm:Pi linkage
Cytogenet Cell Genet, 16 (1-5), 298-301
PubMed 1086184

Elston RC, Namboodiri KK, Lange K, Gedde-Dahl T (1976)
Effect of age on the gm:pi linkage
Birth Defects Orig Artic Ser, 12 (7), 298-301
PubMed 1088254

Gedde-Dahl T, Giles CM, Thorsby E, Olaisen B, Robson EB (1976)
Chido blood group and the HLA region
Cytogenet Cell Genet, 16 (1-5), 307-10
PubMed 975894

Gedde-Dahl T, Giles CM, Thorsby E, Olaisen B, Robson EB (1976)
Chido blood group and the HLA region
Birth Defects Orig Artic Ser, 12 (7), 307-10
PubMed 1024629

Gedde-Dahl T, Robson EB (1976)
Rodgers blood group and the HLA region
Cytogenet Cell Genet, 16 (1-5), 311-2
PubMed 975896

Gedde-Dahl T, Robson EB (1976)
Rodgers blood group and the HLA region
Birth Defects Orig Artic Ser, 12 (7), 311-2
PubMed 1024630

Giles CM, Gedde-Dahl T, Robson EB, Thorsby E, Olaisen B, Arnason A, Kissmeyer-Nielsen F, Schreuder I (1976)
Rga (Rodgers) and the HLA region: linkage and associations
Tissue Antigens, 8 (2), 143-9
PubMed 968900

Hashimoto I, Gedde-Dahl T, Schnyder UW, Anton-Lamprecht I (1976)
Ultrastructural studies in epidermolysis bullosa hereditaria. IV. Recessive dystrophic types with junctional blistering. (Infantile or Herlitz-Pearson type and adult type)
Arch Dermatol Res, 257 (1), 17-32
PubMed 1008602

Hashimoto I, Gedde-Dahl T, Schnyder UW, Anton-Lamprecht I (1976)
Ultrastructural studies in epidermolysis bullosa hereditaria. II. Dominant dystrophic type of Cockayne and Touraine
Arch Dermatol Res, 255 (3), 285-95
PubMed 942257

Hashimoto I, Schnyder UW, Anton-Lamprecht I, Gedde-Dahl T, Ward S (1976)
Ultrastructural studies in epidermolysis bullosa hereditaria. III. Recessive dystrophic types with dermolytic blistering (Hallopeau-Siemens types and inverse type)
Arch Dermatol Res, 256 (2), 137-50
PubMed 962387

Olaisen B, Gedde-Dahl T, Thorsby E (1976)
Localization of the human GLO gene locus
Hum Genet, 32 (3), 301-4
PubMed 939550

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1976)
Bf locus and the HLA region
Cytogenet Cell Genet, 16 (1-5), 345-6
PubMed 975905

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1976)
Bf locus and the HLA region
Birth Defects Orig Artic Ser, 12 (7), 345-6
PubMed 1024638

Teisberg P, Akesson I, Olaisen B, Gedde-Dahl T, Thorsby E (1976)
Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6
Nature, 264 (5583), 253-4
PubMed 1088823

Publications 1975

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
The Gm-Pi linkage: a summary estimate
Cytogenet Cell Genet, 14 (3-6), 327-8
PubMed 53124

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
The Gm-Pi linkage: a summary estimate
Birth Defects Orig Artic Ser, 11 (3), 157-8
PubMed 54196

Gedde-Dahl T, Cook PJ, Fagerhol MK, Pierce JA (1975)
Improved estimate of the Gm-Pi linkage
Ann Hum Genet, 39 (1), 43-50
PubMed 810069

Hashimoto I, Anton-Lamprecht I, Gedde-Dahl T, Schnyder UW (1975)
Ultrastructural studies in epidermolysis bullosa heriditaria. I. Dominant dystrophic type of Pasini
Arch Dermatol Forsch, 252 (3), 167-78
PubMed 1155959

Olaisen B, Teisberg P, Gedde-Dahl T, Thorsby E (1975)
The Bf locus in the HLA region of chromosome 6: linkage and association studies
Humangenetik, 30 (4), 291-6
PubMed 1218859

Teisberg P, Olaisen B, Gedde-Dahl T, Thorsby E (1975)
On the localization of the Gb locus within the MHS region of chromosome No. 6
Tissue Antigens, 5 (4), 257-61
PubMed 1154360

Weitkamp LR, Lovrien EW, Olaisen B, Fenger K, Gedde-Dahl T, Sorensen SA, Conneally PM, Bias WB, Ott J (1975)
Linkage relations of the loci for the MN blood group and red cell acid phosphatase
Cytogenet Cell Genet, 14 (3-6), 446-50
PubMed 1192835

Weitkamp LR, Lovrien EW, Olaisen B, Fenger K, Gedde-Dahl T, Sorensen SA, Conneally PM, Bias WB, Ott J (1975)
Linkage relations of the loci for the MN blood group and red cell acid phosphatase
Birth Defects Orig Artic Ser, 11 (3), 276-80
PubMed 1203495

Publications 1974

Gedde-Dahl T, Teisberg P, Thorsby E (1974)
C3 polymorphism: genetic linkage relations
Clin Genet, 6 (1), 66-72
PubMed 4426132

Olaisen B, Gedde-Dahl T (1974)
Gpt-EBS1 linkage group. General linkage relations
Hum Hered, 24 (2), 178-85
PubMed 4425507

Publications 1973

Gedde-Dahl T (1973)
Population structure in Norway. Inbreeding, distance and kinship
Hereditas, 73 (2), 211-32
PubMed 4713280

Olaisen B, Gedde-Dahl T (1973)
GPT--epidermolysis bullosa simplex (EBS Ogna) linkage in man
Hum Hered, 23 (3), 189-96
PubMed 4760576

Publications 1972

Gedde-Dahl T, Fagerhol MK, Cook PJ, Noades J (1972)
Autosomal linkage between the Gm and Pi loci in man
Ann Hum Genet, 35 (4), 393-9
PubMed 5073686

Publications 1971

Bjercke O, Christensen O, Gedde-Dahl T (1971)
[The standpoint of the Committee for Superannuation Benefits]
Tidsskr Nor Laegeforen, 91 (18), 1425-8
PubMed 5568071

Gedde-Dahl T (1971)
Phenotype-genotype correlations in epidermolysis bullosa
Birth Defects Orig Artic Ser, 7 (8), 107-17
PubMed 5173253

Gedde-Dahl T, Natvig JB, Gundersen K (1971)
Inheritance of Gm(g) and a gene complex Gm a Gm g weak
Clin Genet, 2 (6), 356-66
PubMed 5155313

Publications 1969

Fagerhol MK, Gedde-Dahl T (1969)
Genetics of the Pi serum types. Family studies of the inherited variants of serum alpha-1-antitrypsin
Hum Hered, 19 (4), 354-9
PubMed 5366282

Publications 1968

Gedde-Dahl T, Monn E (1968)
A note on the PGM-1-PTC linkage relation
Acta Genet Stat Med, 18 (5), 420
PubMed 5755851

Publications 1967

Gedde-Dahl T (1967)
[Single gene diseases: general considerations]
Tidsskr Nor Laegeforen, 87 (5), Suppl:431-8
PubMed 4859969

Gedde-Dahl T (1967)
[Diseases showing an irregular family pattern]
Tidsskr Nor Laegeforen, 87 (5), Suppl:477-83
PubMed 6046761

Gedde-Dahl T (1967)
[Consanguinity and disease]
Tidsskr Nor Laegeforen, 87 (5), Suppl:498-504
PubMed 6046765

Gedde-Dahl T (1967)
[Genetic counseling in hereditary diseases]
Tidsskr Nor Laegeforen, 87 (5), Suppl:507-11
PubMed 6046766

Gedde-Dahl T, Monn E (1967)
Linkage relations of the phosphoglucomutase PGM locus in man. Probable linkage to phenylthiocarbamid (PTC) taster locus
Acta Genet Stat Med, 17 (6), 482-94
PubMed 6072882

Publications 1966

Gedde-Dahl T (1966)
[Late and early diagnosis of tuberculosis situations]
Tuberkuloza, 18 (1-3), 68-72
PubMed 16296069

Gedde-Dahl T, Niewiarowska M, Stormorken H (1966)
Parameters of hemostasis in Epidermolysis bullosa: absence of significant deviations from normal
Acta Derm Venereol, 46 (5), 436-42
PubMed 4162945

Publications 1965

GEDDE-DAHL T (1965)
[AAGE JOHANSEN IN MEMORIAM]
Tidsskr Nor Laegeforen, 85, 57
PubMed 14282767

Gedde-Dahl T, Berg K (1965)
Linkage in man: the Inv and the Lp serum type systems
Nature, 208 (5015), 1126
PubMed 5870581

Publications 1963

GEDDE-DAHL T (1963)
[Epidermolysis bullosa congenita simplex with hyperkeratosis palmoplantaris. Therapeutic efforts in a case with generalized blister formation]
Tidsskr Nor Laegeforen, 83, 113-6
PubMed 13946969

GEDDE-DAHL T (1963)
[Epidermolysis bullosa hereditaria: orientation and challenge]
Tidsskr Nor Laegeforen, 83, 95-100
PubMed 13946970

Publications 1957

GEDDE-DAHL T (1957)
[Consequences of the altered epidemiological situation]
Nord Med, 58 (38), 1421-3
PubMed 13484033

Publications 1956

GEDDE-DAHL T (1956)
[Tuberculosis, past, present and future]
Tidsskr Nor Laegeforen, 76 (11), 381-7
PubMed 13337827

Publications 1955

GEDDE-DAHL T (1955)
[Gerontology in Norway]
Nord Med, 54 (27), 1051-3
PubMed 13244886

Publications 1952

GEDDE-DAHL T (1952)
Tuberculous infection in the light of tuberculin matriculation
Am J Hyg, 56 (2), 139-214
PubMed 12985565

Publications 1951

GEDDE-DAHL T (1951)
[Declining tuberculosis incidence and control organization]
Nord Med, 46 (31), 1155-8
PubMed 14863714

GEDDE-DAHL T (1951)
[Chaos or system in rural health control]
Tidsskr Nor Laegeforen, 71 (17), 550-1
PubMed 14884153

GEDDE-DAHL T (1951)
[The duration of BCG allergy]
Nord Med, 45 (4), 122-3
PubMed 14827211

Publications 1950

GEDDE-DAHL T (1950)
[Possibility of determining the effect of mass BCG vaccination]
Nord Med, 43 (10), 444-5
PubMed 14780459

Publications 1949

GEDDE-DAHL T (1949)
[Not Available]
Nord Med, 41 (24), 1055-8
PubMed 18135112